Wabern, Switzerland

Jean-Claude Reubi


Average Co-Inventor Count = 1.9

ph-index = 2

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 2001-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Jean-Claude Reubi

Introduction

Jean-Claude Reubi is a notable inventor based in Wabern, Switzerland. He has made significant contributions to the field of peptide compounds, particularly in relation to somatostatin receptors. With a total of three patents to his name, Reubi's work has implications for both diagnostic and therapeutic applications in oncology.

Latest Patents

One of his latest patents involves peptide compounds that exhibit improved binding affinity to somatostatin receptors. This invention includes a somatostatin analogue as the peptide, which is covalently linked to a chelating group at the N-terminal free amino group. The somatostatin analogue features either an 1-naphthylalanine or a 3-benzothienylalanine residue in its 3-position. This patent also covers the use of the peptide compound labeled with a detectable element or therapeutic radionuclide, along with methods for diagnosing and treating tumors using these labeled compounds.

Another significant patent focuses on radiolabeled peptides for diagnosing and treating breast and prostate tumors, as well as their metastases. This invention utilizes compounds and methods that involve radiolabeled peptides binding to GRP receptors. The peptides are Bombesin analogs, with modifications made to the first and optionally the third amino acid.

Career Highlights

Throughout his career, Jean-Claude Reubi has worked with several prominent companies, including Mallinckrodt, Inc. and Biosynthema Inc. His experience in these organizations has contributed to his expertise in the development of innovative peptide compounds.

Collaborations

Reubi has collaborated with notable professionals in his field, including Wout A Breeman and Ananthachari Srinivasan. These collaborations have likely enhanced the scope and impact of his research and inventions.

Conclusion

Jean-Claude Reubi's contributions to the field of peptide compounds and their applications in oncology highlight his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to improving diagnostic and therapeutic methods for cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…